Annual CFI:
-$3.77B-$628.30M(-20.00%)Summary
- As of today, VRTX annual cash from investing is -$3.77 billion, with the most recent change of -$628.30 million (-20.00%) on December 31, 2024.
- During the last 3 years, VRTX annual cash from investing has fallen by -$3.43 billion (-1005.90%).
- VRTX annual cash from investing is now -1030.48% below its all-time high of $405.17 million, reached on December 31, 2007.
Performance
VRTX Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFI:
-$117.00M+$367.50M(+75.85%)Summary
- As of today, VRTX quarterly cash from investing is -$117.00 million, with the most recent change of +$367.50 million (+75.85%) on September 30, 2025.
- Over the past year, VRTX quarterly cash from investing has increased by +$231.00 million (+66.38%).
- VRTX quarterly cash from investing is now -128.82% below its all-time high of $405.95 million, reached on March 31, 2011.
Performance
VRTX Quarterly Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFI:
-$1.48B+$231.00M(+13.51%)Summary
- As of today, VRTX TTM cash from investing is -$1.48 billion, with the most recent change of +$231.00 million (+13.51%) on September 30, 2025.
- Over the past year, VRTX TTM cash from investing has increased by +$2.36 billion (+61.42%).
- VRTX TTM cash from investing is now -398.63% below its all-time high of $495.33 million, reached on June 30, 2015.
Performance
VRTX TTM Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
VRTX Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -20.0% | +66.4% | +61.4% |
| 3Y3 Years | -1005.9% | +69.5% | -134.5% |
| 5Y5 Years | -205.2% | +52.8% | -42.0% |
VRTX Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -1074.1% | at low | -166.6% | +94.5% | -360.7% | +61.4% |
| 5Y | 5-Year | -3893.2% | at low | -148.0% | +94.5% | -1588.3% | +61.4% |
| All-Time | All-Time | -1030.5% | at low | -128.8% | +94.5% | -398.6% | +61.4% |
VRTX Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | -$117.00M(+75.9%) | -$1.48B(+13.5%) |
| Jun 2025 | - | -$484.50M(-768.3%) | -$1.71B(-1.2%) |
| Mar 2025 | - | -$55.80M(+93.2%) | -$1.69B(+55.2%) |
| Dec 2024 | -$3.77B(-20.0%) | -$821.90M(-136.2%) | -$3.77B(+1.7%) |
| Sep 2024 | - | -$348.00M(+25.0%) | -$3.83B(-6.4%) |
| Jun 2024 | - | -$463.70M(+78.3%) | -$3.60B(-4.6%) |
| Mar 2024 | - | -$2.14B(-141.0%) | -$3.44B(-9.6%) |
| Dec 2023 | -$3.14B(-878.4%) | -$886.50M(-653.2%) | -$3.14B(-51.1%) |
| Sep 2023 | - | -$117.70M(+61.3%) | -$2.08B(+11.4%) |
| Jun 2023 | - | -$303.90M(+83.4%) | -$2.35B(-11.5%) |
| Mar 2023 | - | -$1.83B(-1144.2%) | -$2.10B(-555.2%) |
| Dec 2022 | -$321.10M(+5.8%) | $175.60M(+145.7%) | -$321.10M(+49.1%) |
| Sep 2022 | - | -$384.20M(-524.7%) | -$630.70M(-110.6%) |
| Jun 2022 | - | -$61.50M(-20.6%) | -$299.45M(+5.7%) |
| Mar 2022 | - | -$51.00M(+61.9%) | -$317.59M(+6.8%) |
| Dec 2021 | -$340.90M(-443.0%) | -$134.00M(-153.1%) | -$340.90M(-1025.2%) |
| Sep 2021 | - | -$52.95M(+33.5%) | $36.84M(+123.3%) |
| Jun 2021 | - | -$79.64M(-7.2%) | -$158.14M(-2300.8%) |
| Mar 2021 | - | -$74.31M(-130.5%) | -$6.59M(-106.6%) |
| Dec 2020 | $99.39M(+108.0%) | $243.75M(+198.3%) | $99.39M(+109.5%) |
| Sep 2020 | - | -$247.94M(-444.8%) | -$1.04B(+0.1%) |
| Jun 2020 | - | $71.91M(+127.1%) | -$1.04B(+10.5%) |
| Mar 2020 | - | $31.67M(+103.5%) | -$1.16B(+5.7%) |
| Dec 2019 | -$1.24B(-535.9%) | -$896.99M(-260.2%) | -$1.24B(-232.7%) |
| Sep 2019 | - | -$249.00M(-396.1%) | -$371.33M(-115.6%) |
| Jun 2019 | - | -$50.19M(-28.2%) | -$172.22M(+27.7%) |
| Mar 2019 | - | -$39.14M(-18.6%) | -$238.33M(-22.7%) |
| Dec 2018 | -$194.26M(+54.0%) | -$33.01M(+33.8%) | -$194.26M(-6.3%) |
| Sep 2018 | - | -$49.89M(+57.1%) | -$182.66M(+38.4%) |
| Jun 2018 | - | -$116.30M(-2457.6%) | -$296.45M(-15.6%) |
| Mar 2018 | - | $4.93M(+123.0%) | -$256.44M(+39.3%) |
| Dec 2017 | -$422.35M(-676.0%) | -$21.41M(+86.9%) | -$422.35M(-132.8%) |
| Sep 2017 | - | -$163.68M(-114.6%) | -$181.43M(-3768.2%) |
| Jun 2017 | - | -$76.28M(+52.6%) | $4.95M(-72.0%) |
| Mar 2017 | - | -$160.98M(-173.3%) | $17.69M(-75.9%) |
| Dec 2016 | $73.32M(-71.5%) | $219.51M(+867.1%) | $73.32M(+127.3%) |
| Sep 2016 | - | $22.70M(+135.7%) | -$268.88M(+31.5%) |
| Jun 2016 | - | -$63.54M(+39.7%) | -$392.51M(-676.8%) |
| Mar 2016 | - | -$105.34M(+14.1%) | -$50.53M(-118.8%) |
| Dec 2015 | $257.17M(+255.6%) | -$122.69M(-21.6%) | $268.86M(-26.1%) |
| Sep 2015 | - | -$100.94M(-136.2%) | $363.85M(-26.5%) |
| Jun 2015 | - | $278.44M(+30.1%) | $495.33M(+61.5%) |
| Mar 2015 | - | $214.04M(+872.7%) | $306.77M(+324.2%) |
| Dec 2014 | $72.32M(+188.2%) | -$27.70M(-190.7%) | $72.32M(+143.7%) |
| Sep 2014 | - | $30.55M(-66.0%) | $29.68M(-28.4%) |
| Jun 2014 | - | $89.88M(+540.4%) | $41.44M(+171.6%) |
| Mar 2014 | - | -$20.41M(+71.0%) | -$57.85M(+29.5%) |
| Dec 2013 | -$82.01M(+79.9%) | -$70.34M(-266.3%) | -$82.01M(-764.3%) |
| Sep 2013 | - | $42.31M(+549.5%) | -$9.49M(+94.2%) |
| Jun 2013 | - | -$9.41M(+78.9%) | -$164.09M(+27.6%) |
| Mar 2013 | - | -$44.57M(-2138.9%) | -$226.72M(+44.4%) |
| Dec 2012 | -$407.71M(-291.9%) | $2.19M(+101.9%) | -$407.71M(+48.9%) |
| Sep 2012 | - | -$112.30M(-55.9%) | -$797.67M(-20.1%) |
| Jun 2012 | - | -$72.04M(+68.1%) | -$663.93M(-58.4%) |
| Mar 2012 | - | -$225.56M(+41.8%) | -$419.10M(-297.3%) |
| Dec 2011 | $212.41M(+2809.4%) | -$387.78M(-1908.2%) | $212.41M(-50.7%) |
| Sep 2011 | - | $21.45M(-87.6%) | $430.49M(+5.9%) |
| Jun 2011 | - | $172.79M(-57.4%) | $406.63M(+48.1%) |
| Mar 2011 | - | $405.95M(+339.2%) | $274.49M(+3659.6%) |
| Dec 2010 | $7.30M(+101.4%) | -$169.69M(-6929.6%) | $7.30M(+102.0%) |
| Sep 2010 | - | -$2.41M(-105.9%) | -$370.78M(-13.8%) |
| Jun 2010 | - | $40.65M(-70.7%) | -$325.84M(+27.6%) |
| Mar 2010 | - | $138.76M(+125.3%) | -$450.15M(+11.5%) |
| Dec 2009 | -$508.73M(-41.1%) | -$547.78M(-1388.1%) | -$508.73M(-1516.6%) |
| Sep 2009 | - | $42.52M(+150.8%) | -$31.47M(+82.3%) |
| Jun 2009 | - | -$83.66M(-204.3%) | -$177.85M(-37.8%) |
| Mar 2009 | - | $80.18M(+213.7%) | -$129.07M(+64.2%) |
| Dec 2008 | -$360.65M | -$70.52M(+32.1%) | -$360.65M(-146.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2008 | - | -$103.86M(-197.8%) | -$146.40M(-205.5%) |
| Jun 2008 | - | -$34.87M(+77.0%) | $138.72M(+188.4%) |
| Mar 2008 | - | -$151.40M(-205.3%) | $48.10M(-88.1%) |
| Dec 2007 | $405.17M(+294.4%) | $143.74M(-20.7%) | $405.17M(+2247.1%) |
| Sep 2007 | - | $181.26M(+244.4%) | -$18.87M(+89.5%) |
| Jun 2007 | - | -$125.50M(-161.0%) | -$179.42M(-297.9%) |
| Mar 2007 | - | $205.66M(+173.4%) | -$45.09M(+78.4%) |
| Dec 2006 | -$208.47M(>-9900.0%) | -$280.30M(-1453.3%) | -$208.47M(-624.2%) |
| Sep 2006 | - | $20.71M(+134.6%) | $39.77M(+235.6%) |
| Jun 2006 | - | $8.83M(-79.1%) | -$29.33M(-861.6%) |
| Mar 2006 | - | $42.29M(+231.9%) | $3.85M(+322.3%) |
| Dec 2005 | -$1.73M(-101.6%) | -$32.06M(+33.7%) | -$1.73M(-102.5%) |
| Sep 2005 | - | -$48.38M(-215.2%) | $68.22M(-49.4%) |
| Jun 2005 | - | $42.01M(+14.5%) | $134.75M(-2.0%) |
| Mar 2005 | - | $36.70M(-3.1%) | $137.50M(+28.0%) |
| Dec 2004 | $107.43M(-10.2%) | $37.89M(+108.9%) | $107.43M(+5.5%) |
| Sep 2004 | - | $18.14M(-59.5%) | $101.82M(+51.2%) |
| Jun 2004 | - | $44.76M(+574.3%) | $67.32M(+367.9%) |
| Mar 2004 | - | $6.64M(-79.4%) | $14.39M(-88.0%) |
| Dec 2003 | $119.58M(+849.2%) | $32.28M(+297.3%) | $119.58M(+21.4%) |
| Sep 2003 | - | -$16.36M(-100.1%) | $98.50M(-10.8%) |
| Jun 2003 | - | -$8.18M(-107.3%) | $110.48M(+38.1%) |
| Mar 2003 | - | $111.84M(+898.4%) | $80.00M(+601.2%) |
| Dec 2002 | -$15.96M(+89.0%) | $11.20M(+355.7%) | -$15.96M(+73.1%) |
| Sep 2002 | - | -$4.38M(+88.7%) | -$59.39M(-277.3%) |
| Jun 2002 | - | -$38.66M(-343.5%) | -$15.74M(+49.4%) |
| Mar 2002 | - | $15.87M(+149.3%) | -$31.12M(+78.6%) |
| Dec 2001 | -$145.09M(+38.6%) | -$32.23M(-182.1%) | -$145.09M(+44.0%) |
| Sep 2001 | - | $39.27M(+172.7%) | -$259.22M(+24.9%) |
| Jun 2001 | - | -$54.03M(+44.9%) | -$345.26M(-3.9%) |
| Mar 2001 | - | -$98.10M(+33.0%) | -$332.27M(-40.6%) |
| Dec 2000 | -$236.33M(-749.9%) | -$146.36M(-212.9%) | -$236.33M(-160.5%) |
| Sep 2000 | - | -$46.78M(-14.0%) | -$90.72M(-343.1%) |
| Jun 2000 | - | -$41.03M(-1799.6%) | -$20.47M(-184.4%) |
| Mar 2000 | - | -$2.16M(-187.6%) | $24.27M(-33.3%) |
| Dec 1999 | $36.36M(+278.3%) | -$751.00K(-103.2%) | $36.36M(+62.9%) |
| Sep 1999 | - | $23.47M(+532.6%) | $22.33M(+128.4%) |
| Jun 1999 | - | $3.71M(-62.6%) | $9.78M(+216.6%) |
| Mar 1999 | - | $9.93M(+167.2%) | -$8.39M(+58.9%) |
| Dec 1998 | -$20.39M(+82.8%) | -$14.79M(-235.4%) | -$20.39M(+81.4%) |
| Sep 1998 | - | $10.92M(+175.6%) | -$109.51M(+15.8%) |
| Jun 1998 | - | -$14.45M(-596.5%) | -$130.03M(-451.5%) |
| Mar 1998 | - | -$2.08M(+98.0%) | -$23.57M(+80.2%) |
| Dec 1997 | -$118.81M(-194.5%) | -$103.90M(-982.3%) | -$118.80M(-525.3%) |
| Sep 1997 | - | -$9.60M(-110.4%) | -$19.00M(+62.5%) |
| Jun 1997 | - | $92.00M(+194.6%) | -$50.60M(+63.2%) |
| Mar 1997 | - | -$97.30M(-2273.2%) | -$137.40M(-240.1%) |
| Dec 1996 | -$40.35M(-39.1%) | -$4.10M(+90.0%) | -$40.40M(+16.5%) |
| Sep 1996 | - | -$41.20M(-892.3%) | -$48.40M(-545.3%) |
| Jun 1996 | - | $5.20M(+1833.3%) | -$7.50M(+44.9%) |
| Mar 1996 | - | -$300.00K(+97.5%) | -$13.60M(+53.1%) |
| Dec 1995 | -$29.02M(-105.7%) | -$12.10M(-3933.3%) | -$29.00M(-835.5%) |
| Sep 1995 | - | -$300.00K(+66.7%) | -$3.10M(-111.4%) |
| Jun 1995 | - | -$900.00K(+94.3%) | $27.20M(+2042.9%) |
| Mar 1995 | - | -$15.70M(-213.8%) | -$1.40M(+90.1%) |
| Dec 1994 | -$14.10M(-310.9%) | $13.80M(-54.0%) | -$14.10M(+42.0%) |
| Sep 1994 | - | $30.00M(+201.7%) | -$24.30M(+46.5%) |
| Jun 1994 | - | -$29.50M(-3.9%) | -$45.40M(-66.9%) |
| Mar 1994 | - | -$28.40M(-888.9%) | -$27.20M(-506.0%) |
| Dec 1993 | $6.69M(+171.1%) | $3.60M(-59.6%) | $6.70M(+211.7%) |
| Sep 1993 | - | $8.90M(+178.8%) | -$6.00M(+13.0%) |
| Jun 1993 | - | -$11.30M(-305.5%) | -$6.90M(-155.6%) |
| Mar 1993 | - | $5.50M(+160.4%) | -$2.70M(+71.3%) |
| Dec 1992 | -$9.41M(+62.7%) | -$9.10M(-213.8%) | -$9.40M(-3033.3%) |
| Sep 1992 | - | $8.00M(+212.7%) | -$300.00K(+96.4%) |
| Jun 1992 | - | -$7.10M(-491.7%) | -$8.30M(-591.7%) |
| Mar 1992 | - | -$1.20M | -$1.20M |
| Dec 1991 | -$25.22M | - | - |
FAQ
- What is Vertex Pharmaceuticals Incorporated annual cash from investing?
- What is the all-time high annual cash from investing for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated annual cash from investing year-on-year change?
- What is Vertex Pharmaceuticals Incorporated quarterly cash from investing?
- What is the all-time high quarterly cash from investing for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated quarterly cash from investing year-on-year change?
- What is Vertex Pharmaceuticals Incorporated TTM cash from investing?
- What is the all-time high TTM cash from investing for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated TTM cash from investing year-on-year change?
What is Vertex Pharmaceuticals Incorporated annual cash from investing?
The current annual cash from investing of VRTX is -$3.77B
What is the all-time high annual cash from investing for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high annual cash from investing is $405.17M
What is Vertex Pharmaceuticals Incorporated annual cash from investing year-on-year change?
Over the past year, VRTX annual cash from investing has changed by -$628.30M (-20.00%)
What is Vertex Pharmaceuticals Incorporated quarterly cash from investing?
The current quarterly cash from investing of VRTX is -$117.00M
What is the all-time high quarterly cash from investing for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high quarterly cash from investing is $405.95M
What is Vertex Pharmaceuticals Incorporated quarterly cash from investing year-on-year change?
Over the past year, VRTX quarterly cash from investing has changed by +$231.00M (+66.38%)
What is Vertex Pharmaceuticals Incorporated TTM cash from investing?
The current TTM cash from investing of VRTX is -$1.48B
What is the all-time high TTM cash from investing for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high TTM cash from investing is $495.33M
What is Vertex Pharmaceuticals Incorporated TTM cash from investing year-on-year change?
Over the past year, VRTX TTM cash from investing has changed by +$2.36B (+61.42%)